Granite Investment Partners, LLC Savara Inc Transaction History

Granite Investment Partners, LLC

  • $2.21 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 08, 2018
SELL
$10.49 - $12.87 $163,129 - $200,141
-15,551 Closed
0 $0
Q1 2018

May 04, 2018
SELL
$8.99 - $14.95 $429,443 - $714,146
-47,769 Reduced 75.44%
15,551 $144,000
Q4 2017

Feb 01, 2018
BUY
$8.26 - $16.76 $523,023 - $1.06 Million
63,320
63,320 $940,000

Others Institutions Holding SVRA

# of Institutions
141
Shares Held
158M
Call Options Held
55.6K
Put Options Held
600
View Full List

About Savara Inc

SVRA Quotes by TradingView
  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $307M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email